Imperial Brands Maximising Category Opportunities CAGNY February 2019
|
|
- Adrian Jordan
- 5 years ago
- Views:
Transcription
1 Imperial Brands Maximising Category Opportunities CAGNY February 2019
2 Disclaimer Certain statements in this announcement constitute or may constitute forward-looking statements. Any statement in this announcement that is not a statement of historical fact including, without limitation, those regarding the Company s future expectations, operations, financial performance, financial condition and business is or may be a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those projected or implied in any forward-looking statement. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this announcement. As a result, you are cautioned not to place any reliance on such forward-looking statements. The forwardlooking statements reflect knowledge and information available at the date of this announcement and the Company undertakes no obligation to update its view of such risks and uncertainties or to update the forwardlooking statements contained herein. Nothing in this announcement should be construed as a profit forecast or profit estimate and no statement in this announcement should be interpreted to mean that the future earnings per share of the Company for current or future financial years will necessarily match or exceed the historical or published earnings per share of the Company. This announcement has been prepared for, and only for the members of the Company, as a body, and no other persons. The Company, its directors, employees, agents or advisers do not accept or assume responsibility to any other person to whom this announcement is shown or into whose hands it may come and any such responsibility or liability is expressly disclaimed. 2 CAGNY 21 February 2019
3 Our Investment Case Sustainable Shareholder Returns Guidance Corridor (cc): Net Revenue Growth 1-4% and EPS Growth 4-8% Quality Growth From Tobacco Significant Additive Growth from NGP Simplification & Cost Efficiencies Capital Discipline and Cash Generation Strong Governance and Sustainability Agenda 3 CAGNY 21 February 2019
4 Introducing Imperial Brands Net revenue 7.7bn Op. margin 46% 36,400 employees 160 markets Top 5 markets US Germany UK Australia Spain Cash conversion 95% Debt reduction 0.8bn pa Ten years +10%pa dividend growth 4 CAGNY 21 February 2019
5 Imperial Brands introductory video 5 CAGNY 21 February 2019
6 Consumer & Regulatory Context 6 CAGNY 21 February 2019
7 Changing Landscape Shaping Category Developments Consumption evolving Globalisation & demographics Consumers Lifestyle Innovation Technology & connectivity Industry Government Regulation Category Development 7 CAGNY 21 February 2019
8 Nicotine Consumption Evolving to Reduced Risk Products Growing consumer repertoire 10% 23% 11% 56% 1 category 2 categories 3 categories 4+ categories Multi category usage increasing 20% of smokers also vape 8 CAGNY 21 February 2019 Source: 2018: Global Cross Category Survey (USA, UK, Germany, France, Italy, Japan, Russia), used in last week.
9 Clear Drivers for Vaping Increasing smoker choice Harm reduction 76% Better value than cigarettes Social acceptability 67% 71% c.36m vapers in % CAGR since 2011 Relaxation 67% Source: Millward Brown Global Tracker, UK and US blended Source: Euromonitor October CAGNY 21 February 2019
10 Total tobacco revenues bn Tobacco Market Overview Profit pool in IMB footprint relatively resilient Tobacco Market Revenue: IMB Footprint Low single digit growth Tobacco remains relatively affordable Industry Tobacco Volume CAGR -3% Pricing supports resilient revenue development Additive vapour opportunity CAGNY 21 February 2019 Source: Internal Data & Canback study
11 Resilient Earnings Growth in Regulated Industry History of managing regulatory & excise changes P/E 25.0x +450% EPS index x Average sector P/E (LHS) x 10.0x 5.0x Average EPS indexed to 100 (RHS) EUTPD I 11 CAGNY 21 February 2019 WHO FCTC EU Advertising Directive Australia PHW UK PHW US Federal excise Brazil public places & advertising Australia Plain Packs & Excise UK ban POS Canada Menthol ban EUTPD II France Plain Packs UK Plain Packs
12 Broad Regulatory Approach in Priority Markets Managing Regulation in all environments Less Restricted Advertising restrictions Public smoking restrictions Display bans Standardised packaging Most Restricted 12 CAGNY 21 February 2019
13 US Regulation Evidence-Based Regulatory change supported by science & data Well established rulemaking process Structured approach evidence & science-led Considers risks & benefits to whole population Requires input from all stakeholders Takes time to enact changes 13 CAGNY 21 February 2019
14 US Regulation Update Engaged & supportive of evidence based regulation Tobacco Regulation Lengthy regulatory process for both menthol & low nicotine Multiple stakeholder input; scientific, legal, law enforcement, public health, industry and budgetary stakeholders Risk of unintended consequences Track record of managing regulatory change NGP Regulation Aligned on strict youth access prevention measures Aligned on role of NGP to support harm reduction Positive recent meetings with FDA Supporting tighter regulation 14 CAGNY 21 February 2019
15 Consumer & Regulatory Context Key takeaways Consumer habits are changing Smokers enjoy a wider repertoire of nicotine categories Vaping growing as a smoker preference Tobacco market remains resilient Experienced at managing regulatory change 15 CAGNY 21 February 2019
16 Imperial Brands: Strategy & Choices 16 CAGNY 21 February 2019
17 Our Strategy Creating Something Better for the World s Smokers Next Generation Products blu Adoption Model BELIEVE BELONG BUY BUY AGAIN Strong Cash Flow Right Markets Right Brands Quality Growth High Margins Reinvest Tobacco Maximisation Shareholder Returns Market Repeatable Model 17 CAGNY 21 February 2019 Creating value for shareholders
18 TobMax Strategic Focus: Informed Choices Assets and capabilities aligned to growth opportunities Focus on fewer brands Invest in priority markets Consistent market execution Market Repeatable Model Lean & agile organisation Simple Operating Model Clear investment choices for growth Prioritised strongest brands & invested in main demand shifts Focused on key tobacco profit pools where we can win MRM; our codified RTM model Lean operating model supports growth agenda 18 CAGNY 21 February 2019
19 Right Markets: Prioritisation Focusing resources behind market potential 10 Priority Markets 23 Key Markets 100+ Partner Markets Objective Profitably growing share Driving to full potential Lean portfolio Cost focus Minimise complexity Maintain profit Execution & Support Market-led/tailored initiatives Group & divisional support Standard business tools & initiatives Divisional support Divisional oversight Investment Majority of investment Some new investment Limited investment % of Profits 70% 20% 10% 19 CAGNY 21 February 2019
20 Consistent Market Execution Codified go-to-market model Analyse data, learn, improve and share Portfolio matched to market trends and consumer demand shifts Customer collaboration and strong commercial partnerships Invest consistently in equity of brands that matter Optimal portfolio available in right stores, supported by right activities Clear pricing strategy consistently applied 20 CAGNY 21 February 2019
21 Focused Portfolio Across the Risk Continuum Resources allocated behind product potential Combustible Tobacco Non-Combustible Tobacco Tobacco Free Cigarettes Heated Tobacco Products Snus Vapour Products Oral Nicotine Delivery Nicotine Replacement Therapies Level of Toxicants Acquired: Acquired Dragonite Acquired: Set up: Acquired: Roll-out of myblu Launched: Tobacco Free Snus 21 CAGNY 21 February 2019
22 Vapour: Additive Growth Opportunity for Imperial Growing category Global vaping market RSP ( bn) Low High Retail value of vaping market growing between 300% and 500% Imperial 14% tobacco footprint share with limited impact on our combustible revenue USA 36m smokers 10m vapers Europe 145m smokers 16m vapers IMB tobacco share IMB 9% tobacco 16% share 22 CAGNY 21 February 2019
23 Positive Economics for Smokers and Imperial Retail Selling Price IMB Net Revenue Economic incentive for smokers myblu pod Additive net revenue for Imperial 20 cigarettes Based on RSP per pod (1.5ml) versus pack of 20 FMC Based on net revenue per pod (1.5ml) versus pack of 20 FMC 23 CAGNY 21 February 2019
24 Driving Profitability in Vapour Clear levers being addressed Higher Net Revenue per Pod Lower COGS Route to Market Development Operating Leverage Normalisation of Overheads/A&P Supports higher absolute gross margin Pod innovation Simpler design/ automation E-commerce Normalised retailer margins Driving greater adoption Market expansion Scale benefits Steady state P&L Driving Gross Margin Contribution Driving Operating Margins 24 CAGNY 21 February 2019 Expect to exit FY19 with positive monthly operating profit contribution
25 V Clear Proposition for Smokers & Shareholders Unique set of assets & competencies to deliver growth Delivering to Smokers Delivering to Shareholders Compelling proposition for smokers Increasing Profitability & Returns Compliance & Regulation 25 CAGNY 21 February 2019
26 Delivering Against Our Strategy 26 CAGNY 21 February 2019
27 Delivering Against Our Strategy Building growth momentum in FY18 Growth Brand share Net Revenue EPS Cash conversion Dividend +70bps +2% +5% 97% +10% Tobacco Maximsation Next Gen Products Capital Discipline $ Volumes outperforming market +10 bps 67% +50 bps share FY18 Revenue % from Asset Brands Priority mkt share since FY17 investment Step-up in FY18 FY18: 200m net revenue Additive revenue opportunity Innovative R&D pipeline Investment driving consumer offtake 110m 0.8bn 15.5% cost savings in FY18 further net debt reduction post-tax returns on US acquisition Active capital management through divestments 27 CAGNY 21 February 2019
28 Tobacco Max: Growth Brand Focus Investment delivering share gains Driving sustained share gains in Growth Brands Growing revenue from our strongest equities 5.4% 7.2% 9.2% Asset Brands Portfolio Brands 33% 49% 43% Driving quality revenue Share gains in priority markets 51% 57% 67% Improved tobacco revenue delivery Growth Brand Share Asset Brands % of Revenue 28 CAGNY 21 February 2019
29 USA: Resilient Tobacco Market Acquisition strengthened our market position Industry volume Imperial price/mix -2.5% -2.6% -2.0% -0.8% -1.6% 8.0% 9.7% 6.9% 11.7% -4.0% -4.1% -3.3% Volumes average c. 3% declines -4.8% FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY Medium term outlook: industry volume declines more than offset by price/mix 29 CAGNY 21 February 2019
30 USA: Portfolio Strategy Driving Share Improvements Investment in focus brands and segments Market Share Progression +5bps Cigarette Price Segment Development* 2018 v 2015 FY16 FY17 H118 FY18 Q119-10bps 8.7% 0.2% 0.5% 1.1% -20bps Traditional Premium Premium Value Traditional Discount Deep Discount -30bps -30bps -1.8% 30 CAGNY 21 February 2019 * Segment volume % of total 2018 versus 2015
31 USA: Mass Market Cigars Success Strong portfolio growing faster than market Market Mix Market Growth Market Share 13.5% 12.6% 10.6% 10.9% ITGB Mix 11% 7% 25% 3.5% 4.0% 5.1% 6.8% Homogenised Cigars Natural Leaf Cigars 2015Backwoods ITG Natural ITGB Natural Mass Market Cigar revenue +38% since CAGNY 21 February 2019
32 Focus on Priority Markets Increased investment strengthens share position +90bps Flat -130bps* -80bps* +100bps Investment supporting share gains Consistent financial delivery; managing share Value share growth; excise & pricing affect volume Focus on blonde share; trajectory improving Building market presence and share gains -110bps +310bps +100bps +40bps Strong share position balanced with returns focus Share gains in a difficult excise environment Simplified portfolio drives profitable share growth Strong share gains with West in value segment 32 CAGNY 21 February 2019 * Blonde tobacco share Two year share movement
33 Our blu Adoption Model Omnichannel market execution BELIEVE Building awareness, consideration and trust BUY Stimulating trial and purchase BUY AGAIN Creating repeat purchase BELONG Fostering loyalty through community and belonging 33 CAGNY 21 February 2019
34 Strong Consumer Awareness for blu blu resonating strongly with smokers & vapers Unaided awareness: Smokers Unaided awareness: Vapers 34 CAGNY 21 February 2019 Source: Feb 2019 survey conducted by Engine among a sample of 2, US adults; % of respondents
35 The Pledge by blu Inspiring adult smokers to make a change Engaging Adult Smokers & Vapers Video Views 8,597,649 Results after 7 weeks Conversation +2,100% Positive Sentiment +54% 35 CAGNY 21 February 2019
36 Imperial Brands: blu Pledge video 36 CAGNY 21 February 2019
37 USA: myblu building presence in retail Consumer off-take growing Pods: Consumer off-take Retail presence building Growing consumer off-take Category has slowed in recent months Increasing blu adoption Jan Feb Mar Apr May June July Aug Sep Oct Nov Dec Jan CAGNY 21 February 2019 Source: Aggregated IRI data
38 UK: myblu building presence in retail Consumer offtake growing Pods: Consumer offtake Creating the pod category in the UK Distribution building Leading unaided awareness Consumer off-take growing Apr May June July Aug Sep Oct Nov Dec Jan #2 market share 38 CAGNY 21 February 2019 Source: Aggregated EPOS data for traditional retail
39 myblu building retail presence in priority markets Leading retail share and driving category growth Germany #1 in retail 3 months post national launch Successful market roll-outs Italy #1 in retail Category doubled Japan #1 in retail Leading in distribution Russia #2 in retail Following recent launch France #1 in retail Leading device sales Also launched in.. Spain Austria Canada 39 CAGNY 21 February 2019 Source: Nielsen data
40 Clear Innovation Thinking Driving portfolio evolution Consumer focus Flavour Design Satisfaction Convenience Other focus Safety Cost IP 40 CAGNY 21 February 2019
41 Dynamic Innovation Supports Smoker Conversion Further rollouts in FY19 Vapour Nicotine salts Connectivity 3D Flavour Next gen pod Other NGP Tobacco Free Snus Heated Tobacco 41 CAGNY 21 February 2019
42 Imperial Brands: Video on 3D Flavour and Connected Device 42 CAGNY 21 February 2019
43 PULZE Heated Tobacco Launch Better tobacco taste Consecutive smokes Easy to use & clean Options to personalise the experience Tested well with consumers 43 CAGNY 21 February 2019
44 Imperial Brands: Video on Pulze 44 CAGNY 21 February 2019
45 $ Strong Cash Delivery Debt repayment of c 0.8bn pa over 5 years Free Cashflow m Dividend m 2,121 2,421 2,344 2,551 1,165 1,301 1,428 1,577 1,747 1,796 FY14 FY15 FY16 FY17 FY18 Dividend pay-out ratio of FCF (%) FY14 FY15 FY16 FY17 FY CAGNY 21 February 2019 Free cashflow = Change in net debt before FX, dividend & US acquisition
46 $ Strong Capital Discipline Drives returns on assets and deleverage Net Debt/EBITDA Return on Invested Capital 3.4x 3.3x 3.0x 2.9x >14% post tax ROIC Growing despite M&A & investments 2.6x Rigorous returns criteria for M&A Capital light NGP model Active management of capital bn of debt repaid over 5 years 46 CAGNY 21 February 2019 ROIC = Adjusted net operating profit after tax divided by adjusted total equity and reported net debt
47 $ Strategic Focus: Right Markets, Brands & Products More active capital allocation Strategic Focus Cost & Capital Discipline Capital Priorities $ Fewer brands, SKUs Market prioritisation NGP growth opportunity Lean operating model/ footprint optimisation More active portfolio management Divestments and exits Proceeds of up to 2bn over next c. 12 months Ongoing debt reduction Investment in growth opportunities Shareholder returns 47 CAGNY 21 February 2019
48 Our Investment Case Sustainable Shareholder Returns Guidance Corridor (cc): Net Revenue Growth 1-4% and EPS Growth 4-8% Quality Growth From Tobacco Significant Additive Growth from NGP Simplification & Cost Efficiencies Capital Discipline and Cash Generation Strong Governance and Sustainability Agenda 48 CAGNY 21 February 2019
FOCUSED ON QUALITY GROWTH
OUR STRATEGY FOCUSED ON QUALITY GROWTH OUR STRATEGY Our strategy is aligned to our purpose of creating something better for the world s smokers and focuses on driving results in three key areas. In Tobacco
More informationSWEDISH MATCH RESULTS PRESENTATION Q3 2017
SWEDISH MATCH RESULTS PRESENTATION Q3 2017 DISCLAIMER The information contained in this presentation has not been independently verified and is subject to change without notice and neither Swedish Match,
More informationInvestor Day EEMA Region Lausanne, September 29, Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free
Investor Day EEMA Region Lausanne, September 29, 2016 Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free Agenda Overview and Key Results Vision and Strategic Pillars
More informationGlobal E-Cigarette Market- Industry Analysis & Outlook ( )
Global E-Cigarette Market- Industry Analysis & Outlook (2016-2020) ----------------------------------------- Executive Summary Electronic cigarettes, also known as E-cigarettes, electronic nicotine delivery
More informationInvestor Day Lausanne, September 27, 2018
Investor Day Lausanne, September 27, 2018 Jacek Olczak Chief Operating Officer OPERATING AROUND THE ADULT CONSUMER 2 Operating Around the Adult Consumer CC RRPs PMI Combustible Cigarette Performance Reduced-Risk
More informationSlide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A
Slide 1 Financial update and closing remarks Jesper Brandgaard EVP and CFO RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A Slide 2 Forward-looking statements Novo Nordisk s reports filed with or
More informationCategory ADVICE. For Tobacconists Only.
2018 For Tobacconists Only www.bestway.co.uk www.batleys.co.uk MARKET INSIGHT Availability of best selling brands is absolutely critical 1 in 4 adult smokers would leave the store without making a purchase
More informationIncrease in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014
Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) ( ) H1 2014 revenues and results - 24 July 2014 Forward-looking statement This presentation contains
More informationInvestor Day LA&C Region Lausanne, September 29, Jeanne Pollès President, Latin America & Canada Region
Investor Day LA&C Region Lausanne, September 29, 2016 Jeanne Pollès President, Latin America & Canada Region Agenda Regional Overview and Performance Regional Strategies Key Markets Conclusion 2 LA&C Regional
More informationSWEDISH MATCH RESULTS PRESENTATION Q4 2018
SWEDISH MATCH RESULTS PRESENTATION Q4 2018 DISCLAIMER The information contained in this presentation has not been independently verified and is subject to change without notice and neither Swedish Match,
More informationVontobel Viewpoints FDA New Direction on Tobacco Our Take
Quality Growth Boutique TM Vontobel Viewpoints On July 28, 2017, the new Commissioner of the U.S. Food and Drug Administration (FDA), Scott Gottlieb, surprised the markets by launching a consultation paper
More informationQ Investor Kit JANUARY-JUNE 2014
Q2 2014 Investor Kit JANUARY-JUNE 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco
More informationQ Investor Kit January December 2014
Q4 2014 Investor Kit January December 2014 Highlights for Q4 Sales up for all product areas and operating profit from product areas up by 8% Scandinavian hoarding for snus prior to tax increase in January
More informationA world leader in allergy immunotherapy
A world leader in allergy immunotherapy Investor Relations presentation June 2017 1 I Investor Relations presentation I June 2017 ALK: Towards redefining treatment of severe allergies The commercial leader
More informationQ Investor Kit JANUARY-MARCH 2014
Q1 2014 Investor Kit JANUARY-MARCH 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco
More informationJanuary 30, 2018 Dow Wilson President and Chief Executive Officer
Acquisition of SIRTeX January 30, 2018 Dow Wilson President and Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking
More informationDIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM
November 28, 2017 DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM Dr. Jürgen Wunram Agenda Diebold Nixdorf AG History and shareholder structure Market trends, strategy and progress of integration Diebold Nixdorf
More informationQ Investor Kit JANUARY-JUNE 2013
Q2 2013 Investor Kit JANUARY-JUNE 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)
More informationAn exciting combination in a high growth, high margin Nutrition category. Name of chairman
An exciting combination in a high growth, high margin Nutrition category 2 Vevey, December 14, 2006 Disclaimer This presentation contains forward looking statements which reflect Management s current views
More informationFor personal use only
HY18 Result Presentation 13 February 2018 Dig Howitt Brent Cubis CEO & President CFO HY18 Result highlights Strong momentum across developed markets continues Developed market unit growth up 12% Strengthening
More informationDuPont Nutrition & Health Craig Binetti, President
Craig Binetti, President Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this
More informationAltria Group Inc (MO-NYSE)
March 20, 2015 Altria Group Inc (MO-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 08/12/2009 Current Price (03/19/15) $51.27 Target Price $54.00
More informationDesigning a Smoke-Free Future
Designing a Smoke-Free Future Morgan Stanley Global Consumer & Retail Conference New York, November 14, 2017 Jacek Olczak Chief Financial Officer Martin King President, Asia Region Forward-Looking and
More informationWalgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs
Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs Second quarter sales up 3.1 percent to record $17.0 billion
More informationSlide 1. International Operations update. Mike Doustdar EVP International Operations. YASMIN FIEDLER, Germany Yasmin has type 1 diabetes
Slide 1 International Operations update Mike Doustdar EVP International Operations YASMIN FIEDLER, Germany Yasmin has type 1 diabetes Slide 2 Forward-looking statements Novo Nordisk s reports filed with
More informationA GLOBAL LEADER IN PERSONALIZED NUTRITION
A GLOBAL LEADER IN PERSONALIZED NUTRITION Forward Looking Statements Management will make forward-looking statements during this presentation. Actual results could differ from those projected in such forward-looking
More informationADM to Acquire Neovia and Probiotics International Limited. July 2, 2018
ADM to Acquire Neovia and Probiotics International Limited July 2, 2018 Safe Harbor Statement 2 Some of our comments constitute forward-looking statements that reflect management s current views and estimates
More informationST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015
ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 1 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the meaning of the Private Securities Litigation
More information1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes
1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements
More informationIndustry Post-Regulation. E-Cigarette Summit Tim Phillips, ECigIntelligence. 17 th November
Industry Post-Regulation E-Cigarette Summit 217 Tim Phillips, ECigIntelligence 17 th November 217 www.ecigintelligence.com Agenda 1 2 3 Post-TPD: Has regulation been a success? Heated Tobacco: a success?
More informationQ Investor Kit January December 2015
Q4 2015 Investor Kit January December 2015 Summary and Overview 2 Q4 and full year 2015: Headline numbers Sales for the full year increased by 9 percent and for the fourth quarter by 5 percent. In local
More informationInvestor Day Lausanne, June 21, André Calantzopoulos Chief Operating Officer Philip Morris International
Investor Day Lausanne, June 21, 2012 André Calantzopoulos Chief Operating Officer Philip Morris International Agenda Industry Overview Competitive Landscape Fiscal & Regulatory Environment Regional Overview
More informationAnnual Shareholders Meeting
Annual Shareholders Meeting February 8, 2018 Dow R. Wilson, President and Chief Executive Officer Forward-Looking Statements Except for historical information, this presentation contains forward-looking
More informationACHIEVING SMOKEFREE AOTEAROA BY2025
ACHIEVING SMOKEFREE AOTEAROA BY2025 Monitoring and evaluation plan CONTENTS Acknowledgements 1 Introduction 2 Logic model 3 Sources of information 4 Monitoring progress towards the SFA 2025 goal 4 System
More informationPutting ALK on the right growth trajectory
Putting ALK on the right growth trajectory Økonomisk Ugebrevs Kapitalmarkedseftermiddag 15. marts 2018 Per Plotnikof, VP Corporate Communications and IR Marts 2018 Allergy: a global disease with a large
More information2014 CAGNY Investor Presentation. February 19, 2014
2014 CAGNY Investor Presentation February 19, 2014 Management Team Participants Howard Willard EVP and Chief Financial Officer, Altria Group, Inc. Dave Beran President and Chief Operating Officer, Altria
More informationThe Cigarette Market in Netherlands
The Cigarette Market in Netherlands Product Code: CG0148MR Published Date: April 2015 Report Price: US$ 975 (Single Copy) Synopsis Cigarettes in Austria report is a qualitative report providing extensive
More informationForward Looking Information
Vital Signs, Inc. Forward Looking Information Except for historical information discussed, the statements made today are forward-looking statements that involve risks and uncertainties. Investors are cautioned
More informationDELICA D:5 ACTIVE GEAR 0
DELICA D:5 ACTIVE GEAR 0 1 1. FY2017 1Q Results 2. FY2017 1Q Results by Region 3. FY2017 Forecast 4. Initiatives for the Future FY2017 1Q Results Summary (vs. FY2016 1Q) (Apr-Jun 2016) (Apr-Jun 2017) (billion
More informationAcquisition of Novartis Influenza Vaccines Business. 27 th October 2014
1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include
More information1Q 2014 Earnings Release
1Q 2014 Earnings Release April 2014 DISCLAIMER Financial results for 1Q 2014 are provisional and accordingly subject to change according to the outside independent auditors review. This presentation contains
More information4 th Quarter 2017 Earnings Review & Investor Update
4 th Quarter 2017 Earnings Review & Investor Update February 5, 2018 1 Forward-Looking Information This presentation contains statements about the Company s future plans and prospects that constitute forward-looking
More informationLars Dahlgren. President and CEO
Lars Dahlgren President and CEO 1 Summing up 2013 Sales in line with last year but decreasing profits Sales +1% Operating profit -5% Earnings per share 13.63 SEK (14.33) Financially challenging year but
More informationTobacco Insights May
Tobacco Insights 2015 - May Product Code: TI0017MR Published Date: June 2015 Report Price: US$ 150 (Single Copy) Synopsis Tobacco Insights 2015 - May report is a qualitative report providing extensive
More informationQ Investor Kit JANUARY-MARCH 2013
Q1 2013 Investor Kit JANUARY-MARCH 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)
More informationGenomic Health. Kim Popovits, Chairman, CEO and President
Genomic Health Kim Popovits, Chairman, CEO and President Safe Harbor Statement Various remarks that we make in this presentation that are not historical, including those about our future financial and
More informationCowen Healthcare Conference
Cowen Healthcare Conference Shire plc March 9, 2010 Michael Cola President, Specialty Pharmaceuticals Our purpose We enable people with life-altering conditions to lead better lives 1 THE SAFE HARBOR STATEMENT
More information(LO-NYSE) SUMMARY. Risk Level *
February 12, 2015 Lorillard Inc. (LO-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 05/22/2012 Current Price (02/11/15) $67.55 Target Price $71.00
More informationCompany presentation. SEB Nordic Seminar Bella Sky, Copenhagen. Carsten Hellmann, President & CEO 9 January 2018
Company presentation SEB Nordic Seminar Bella Sky, Copenhagen Carsten Hellmann, President & CEO 9 January 2018 Allergy: a global disease with a large unmet need >500 million people affected by allergic
More informationFIRSTQUARTER2018 RESULTSPRESENTATION
FIRSTQUARTER2018 RESULTSPRESENTATION May 14 th 2018 Juan Lladó CEO 1 DISCLAIMER This document has been prepared by Técnicas Reunidas S.A. (the Company) solely for use at presentations held in connection
More informationAstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance. Becoming Global Leaders In Diabetes
AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance Becoming Global Leaders In Diabetes 19th December 2013 Cautionary Statement Regarding Forward-Looking Statements In order,
More informationHarm de Wildt MD TNI
Harm de Wildt MD TNI Nutreco Capital Markets Day Derbyshire, UK 17 September 1 2013 Agenda 1 2 3 Market overview Animal Nutrition Europe Animal Nutrition strategic priorities Application Solution Centres
More informationAnnual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 27, 2018
Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 27, 2018 Árpád Könye Chairman of the Board of Directors Total Cigarette Market Czech Republic Total cigarette market down
More informationJT Group Consolidated Financial Results 2018 First Quarter Results
JT Group Consolidated Financial Results 2018 First Quarter Results Naohiro Minami JT Group Chief Financial Officer *Please be reminded that the figures shown on these slides may differ from those shown
More informationTobacco Free Ireland Action Plan
Tobacco Free Ireland Action Plan Tobacco Free Ireland, the report of the Tobacco Policy Review Group, was endorsed by Government, and published in October 2013. It builds on existing tobacco control policies
More informationMitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association
Regulatory Public Laws Compliance & Education Policies Science & Enforcement & Communications The FDA Center for Tobacco Products (CTP): Its Role in Reducing Tobacco Use Mitch Zeller, Director, Center
More informationJEFFERIES 2016 HEALTHCARE CONFERENCE. June 2016
JEFFERIES 2016 HEALTHCARE CONFERENCE June 2016 Company disclaimer This presentation contains forward-looking statements that provide our expectations or forecasts of future events such as new product introductions,
More informationTELECONFERENCE Q August 2015
TELECONFERENCE Q2 2015 19 August 2015 Company disclaimer This presentation contains forward-looking statements that provide our expectations or forecasts of future events such as new product introductions,
More informationUniversal Biosensors, Inc.
Universal Biosensors, Inc. ARBN 121 559 993 Buchan Three Tickers Presentation 18 th September 2013 1 Important Disclaimer This presentation is intended to provide a general outline only and is not intended
More informationOur Focus on Driving Shareholder Value Begins Here
Our Focus on Driving Shareholder Value Begins Here in the fields from which we source our tobacco leaf. In 2011 we purchased approximately 440 million kilograms of packed tobacco leaf. Our largest sources
More informationSecond Quarter and First Half 2011 Conference Call. 29 July, SORIN GROUP Presentation 1
Second Quarter and First Half 2011 Conference Call 29 July, 2011 SORIN GROUP Presentation 1 DISCLAIMER This presentation contains management preliminary estimates and forward-looking statements, including
More informationOpen Letter to Financial Secretary, Hong Kong SAR Government
Open Letter to Financial Secretary, Hong Kong SAR Government 1 6 February 2018 Raising Tobacco Tax by 100% to Lower Smoking Prevalence and Achieve Tobacco Endgame in 2027 Hong Kong: Tobacco kills nearly
More informationAltria Group Inc. Ticker: MO
Altria Group Inc. Ticker: MO Business Description Altria Group Inc. through its subsidiaries manufactures and sells cigarettes, other tobacco products, machine-made large cigars and pipe tobacco. It also
More informationQ2 INVESTOR KIT JANUARY-JUNE 2011
Q2 INVESTOR KIT JANUARY-JUNE 2011 Swedish Match reporting segments Reporting segments following the transaction with STG on October 1, 2010 Snus and snuff - Swedish snus in Scandinavia and US - US moist
More informationRESPONSE FROM ALTRIA:
RESPONSE FROM ALTRIA: FDA Regulation of Tobacco http://www.altria.com/en/cms/about_altria/federal_regulation_of_tobacco/default.aspx?src=top_nav http://www.fda.gov/tobaccoproducts/default.htm The Food
More informationValue creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO
Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO Coloplast has four business areas all with global sales presence Group revenue
More informationFor personal use only
Virtus Health (ASX. VRT) Sue Channon CEO and Glenn Powers CFO Navigating Future Growth, UBS Australasian Conference 7 November, 2016 DISCLAIMER 2 The material in this presentation has been prepared by
More informationTelekom Austria Group Results for the 1st Quarter May 27, 2003
Telekom Austria Group Results for the 1st Quarter 2003 May 27, 2003 1 Cautionary Statement This presentation contains certain forward-looking statements. Actual results may differ materially from those
More informationWhy comprehensive TC is essential for successful harm reduction
Why comprehensive TC is essential for successful harm reduction E-cigarette summit London 15 th November 2018 Deborah Arnott Chief Executive ASH (Action on Smoking and Health) Declaration of Interest ASH
More informationPatrick J. Sullivan Chief Executive Officer. January 9, 2018 Investor Presentation
Patrick J. Sullivan Chief Executive Officer January 9, 2018 Investor Presentation Forward Looking Statement This presentation may contain forward-looking statements concerning Insulet's expectations, anticipations,
More informationNomura Healthcare Conference
Nomura Healthcare Conference Sebastien Martel Head of Investor Relations London, July 1st, 2011 Forward Looking Statements 2 This presentation contains forward-looking statements as defined in the Private
More informationWelcome to the Full -Year Results Press Conference
Welcome to the Full -Year Results Press Conference Disclamer This presentation contains forward looking statements which reflect Management s current views and estimates. The forward looking statements
More informationThe Global Tobacco Problem
Best Practices in Tobacco Control Policy: An Update Johanna Birckmayer, PhD, MPH Campaign for Tobacco Free Kids The Global Tobacco Problem Almost one billion men and 250 million women are daily smokers
More informationResults Presentation 2Q FY March Win-Partners Co., Ltd. (3183)
Results Presentation 2Q FY March 2018 Win-Partners Co., Ltd. (3183) 2Q results ending September 2017 Consolidated results summary ( mil)2q to Sep 2016 Sep 2017 YoY OE Sales 27,713 29,753 +7.4% 29,500 Operating
More informationJP Morgan 2011 Healthcare Conference. David Redfern, Chief Strategy Officer 12 January 2011
JP Morgan 2011 Healthcare Conference David Redfern, Chief Strategy Officer 12 January 2011 GSK performance through patent cliff + Avandia GSK patent cliff + Avandia 2006-2009 US turnover for se elected
More informationWELCOME TO ACTELION S AGM 2015
WELCOME TO ACTELION S AGM 2015 08 May 2015 Copyright 2015 Actelion Pharmaceuticals Ltd ACTELION S ANNUAL GENERAL MEETING 2015 MEETING STRUCTURE Opening Remarks Business Review 2014 Agenda & Proposals Jean-Pierre
More informationXXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology
Company Update Industrial & Consumer Technology (XXII - $2.81 - Buy) COMPANY NOTE JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com Sales and trading 7 a.m. to 7 p.m. ET,
More informationColgate Palmolive India Limited Slide 1
Colgate Palmolive India Limited Slide 1 Colgate Palmolive India Ltd Colgate Palmolive India Limited Slide 2.since 1937 Disclaimer This Presentation and its related publication, release, webcast or communication
More informationCochlear Limited 2018 Annual General Meeting Chairman s Address
Cochlear Limited 2018 Annual General Meeting Chairman s Address 16 October 2018 Rick Holliday-Smith Chairman Ladies and gentlemen Cochlear reported a record net profit of $246 million for FY18, an increase
More informationJefferies 2014 Global Healthcare Conference November Because people depend on us
Jefferies 2014 Global Healthcare Conference November 2014 Because people depend on us Forward-looking statements This presentation and information communicated verbally to you may contain certain projections
More informationSMOKE - FREE ONTARIO. The Next Chapter For a Healthier Ontario
SMOKE - FREE The Next Chapter - 2018 For a Healthier Ontario TABLE OF CONTENTS The Tobacco Burden 1 Ontario s Progress 2 The Imperative 4 Smoke-Free Ontario Strategy: Roadmap to Success 5 Strategic Priorities
More informationGROWTH NOW! Franck Riboud
GROWTH NOW! Franck Riboud June 15 h, 2010 Disclaimer This document contains certain forward-looking statements concerning DANONE. Although DANONE believes its expectations are based on reasonable assumptions,
More informationTELECONFERENCE Q November 2015
TELECONFERENCE Q3 2015 4 November 2015 Company disclaimer This presentation contains forward-looking statements that provide our expectations or forecasts of future events such as new product introductions,
More informationSpecialized Nutrition in China: a Strong and Sustainable engine for growth
Investor Seminar October 22, 2018 Specialized Nutrition in China: a Strong and Sustainable engine for growth Bridgette HELLER EVP, Danone Specialized Nutrition Bridgette Heller 3 years at Danone 2016 EVP
More informationShareholder Presentation Annual Meeting 2018
Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)
More informationFROM TOBACCO TO SOMETHING BETTER
FROM TOBACCO TO SOMETHING BETTER OUR APPROACH TO NEXT GENERATION PRODUCTS www.imperialbrandsplc.com WELCOME Imperial Brands is a dynamic fast moving consumer goods company borne out of a strong tobacco
More informationCorporate Update Simon Hubbert, CEO Bill Kullback, CFO June, 2015
(Nasdaq:EVAR) Corporate Update Simon Hubbert, CEO Bill Kullback, CFO June, 2015 Safe Harbor This presentation contains forward-looking statements as that term is defined in the Private Securities Litigation
More informationValue creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO
Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO Forward-looking statements The forward-looking statements contained in this presentation,
More informationSlide 1. Investor presentation. London 5 February 2019
Slide Investor presentation London 5 February 209 Slide 2 Forward-looking statements Novo Nordisk s reports filed with or furnished to the US Securities and Exchange Commission (SEC), including this presentation
More informationEnel Américas 1Q 2018 results
Enel Américas 1Q 2018 results 1Q 2018 results Highlights of the period EBITDA of 820 musd, an increase of 26% vs 1Q 2017 Generation EBITDA increased by 17% due to better prices in Argentina and consolidation
More informationForward-Looking Statements
Investor Presentation May 2012 Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended.
More informationInvestor Presentation
Investor Presentation February 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities
More informationInvestor Day Lausanne, September 27, 2018
Investor Day Lausanne, September 27, 2018 André Calantzopoulos Chief Executive Officer PMI: Strong Business with a Strong Future Enormous opportunity from RRPs is undiminished Our goal: convincing people
More informationTotal Face Group Limited
Total Face Group Limited 2017 Half Year Results Presentation Contents Results Highlights Highlights Half Year Results Revenue Bridge Revenue Breakdown Clinic Profitability Profit & Loss Financial Position
More informationA world leader in allergy immunotherapy
A world leader in allergy immunotherapy Company presentation Per Plotnikof, VP Corporate Communications and IR 1 I ALK at a glance Commercial leader and foremost innovator within respiratory allergies
More informationBDS ANALYTICS Top Ten Cannabis Market Trends for 2019
BDS ANALYTICS Top Ten Cannabis Market Trends for 2019 Presented by: Roy Bingham CEO and Co-Founder roy@bdsanalytics.com Jessica Lukas VP, Consumer Insights Jessica@bdsanalytics.com 2018 PREDICTIONS https://bdsanalytics.com/bds-analytics-top-10-cannabis-market-trends-2018/
More informationThe Cigarette Market in Greece
The Cigarette Market in Greece Product Code: CG0145MR Published Date: April 2015 Report Price: US$ 975 (Single Copy) Synopsis Cigarettes in Greece report is a qualitative report providing extensive and
More informationON SHELF AVAILABILITY ALIGNMENT PROJECT 2011 ASIA PAC SURVEY RESULTS
ON SHELF AVAILABILITY ALIGNMENT PROJECT 2011 ASIA PAC SURVEY RESULTS Introduction The ECR Asia Pacific OSA working group conducted an online survey between July and September 2011 aimed at gaining insights
More informationColoplast A/S. Investor presentation 1H 2005/06
Coloplast A/S Investor presentation 1H 2005/06 2 Coloplast Coloplast products and services help patients achieve greater independence from medical challenges in 4 areas: Ostomy care, continence care, wound
More informationHip & Knee Orthopedic Surgical Implants Market: Country wise Outlook
Global Hip & Knee Orthopedic Surgical Implants market is projected to reach more than US$ 12 Billion by 2021, at a CAGR of XX% from 2016 to 2021. The growing prevalence of symptomatic osteoarthritis and
More information